Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.

Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G, Botti G, Melillo RM, Franco R.

Cancers (Basel). 2019 Jun 7;11(6). pii: E785. doi: 10.3390/cancers11060785.

2.

Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D.

La Sala L, Mrakic-Sposta S, Tagliabue E, Prattichizzo F, Micheloni S, Sangalli E, Specchia C, Uccellatore AC, Lupini S, Spinetti G, de Candia P, Ceriello A.

Cardiovasc Diabetol. 2019 Feb 25;18(1):18. doi: 10.1186/s12933-019-0824-2.

3.

Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.

Prattichizzo F, Giuliani A, Mensà E, Sabbatinelli J, De Nigris V, Rippo MR, La Sala L, Procopio AD, Olivieri F, Ceriello A.

Ageing Res Rev. 2018 Dec;48:87-98. doi: 10.1016/j.arr.2018.10.003. Epub 2018 Oct 15. Review.

PMID:
30336272
4.

Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low-grade inflammation the neglected component?

Prattichizzo F, De Nigris V, Micheloni S, La Sala L, Ceriello A.

Diabetes Obes Metab. 2018 Nov;20(11):2515-2522. doi: 10.1111/dom.13488. Epub 2018 Sep 6. Review.

PMID:
30073768
5.

Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability.

La Sala L, Mrakic-Sposta S, Micheloni S, Prattichizzo F, Ceriello A.

Cardiovasc Diabetol. 2018 Jul 23;17(1):105. doi: 10.1186/s12933-018-0748-2.

6.

Novel insights into the regulation of miRNA transcriptional control: implications for T2D and related complications.

La Sala L, Micheloni S, De Nigris V, Prattichizzo F, Ceriello A.

Acta Diabetol. 2018 Oct;55(10):989-998. doi: 10.1007/s00592-018-1149-4. Epub 2018 May 7. Review.

PMID:
29732466
7.

Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages.

Prattichizzo F, De Nigris V, Mancuso E, Spiga R, Giuliani A, Matacchione G, Lazzarini R, Marcheselli F, Recchioni R, Testa R, La Sala L, Rippo MR, Procopio AD, Olivieri F, Ceriello A.

Redox Biol. 2018 May;15:170-181. doi: 10.1016/j.redox.2017.12.001. Epub 2017 Dec 6.

8.

A donor splice site mutation in CISD2 generates multiple truncated, non-functional isoforms in Wolfram syndrome type 2 patients.

Cattaneo M, La Sala L, Rondinelli M, Errichiello E, Zuffardi O, Puca AA, Genovese S, Ceriello A.

BMC Med Genet. 2017 Dec 13;18(1):147. doi: 10.1186/s12881-017-0508-2.

9.

A unique plasma microRNA profile defines type 2 diabetes progression.

de Candia P, Spinetti G, Specchia C, Sangalli E, La Sala L, Uccellatore A, Lupini S, Genovese S, Matarese G, Ceriello A.

PLoS One. 2017 Dec 4;12(12):e0188980. doi: 10.1371/journal.pone.0188980. eCollection 2017.

10.

Inflammageing and metaflammation: The yin and yang of type 2 diabetes.

Prattichizzo F, De Nigris V, Spiga R, Mancuso E, La Sala L, Antonicelli R, Testa R, Procopio AD, Olivieri F, Ceriello A.

Ageing Res Rev. 2018 Jan;41:1-17. doi: 10.1016/j.arr.2017.10.003. Epub 2017 Oct 31. Review.

PMID:
29081381
11.

The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.

Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A.

Nutrients. 2017 Apr 28;9(5). pii: E437. doi: 10.3390/nu9050437. Review.

12.

The pivotal role of high glucose-induced overexpression of PKCβ in the appearance of glucagon-like peptide-1 resistance in endothelial cells.

Pujadas G, De Nigris V, La Sala L, Testa R, Genovese S, Ceriello A.

Endocrine. 2016 Nov;54(2):396-410. Epub 2015 Nov 19.

PMID:
26585565
13.

Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.

Liotti F, Collina F, Pone E, La Sala L, Franco R, Prevete N, Melillo RM.

Stem Cells. 2017 Jan;35(1):135-146. doi: 10.1002/stem.2492. Epub 2016 Sep 21.

14.

The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory.

Pujadas G, De Nigris V, Prattichizzo F, La Sala L, Testa R, Ceriello A.

Endocrine. 2017 Jun;56(3):509-520. doi: 10.1007/s12020-016-1052-0. Epub 2016 Aug 16.

15.

"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 Diabetes.

Prattichizzo F, De Nigris V, La Sala L, Procopio AD, Olivieri F, Ceriello A.

Oxid Med Cell Longev. 2016;2016:1810327. doi: 10.1155/2016/1810327. Epub 2016 Jun 1. Review.

16.

Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells.

La Sala L, Cattaneo M, De Nigris V, Pujadas G, Testa R, Bonfigli AR, Genovese S, Ceriello A.

Cardiovasc Diabetol. 2016 Apr 30;15:71. doi: 10.1186/s12933-016-0390-9.

17.

The simultaneous control of hyperglycemia and GLP-1 infusion normalize endothelial function in type 1 diabetes.

Ceriello A, De Nigris V, Pujadas G, La Sala L, Bonfigli AR, Testa R, Uccellatore A, Genovese S.

Diabetes Res Clin Pract. 2016 Apr;114:64-8. doi: 10.1016/j.diabres.2016.01.019. Epub 2016 Mar 9.

PMID:
27103371
18.

Short-term high glucose exposure impairs insulin signaling in endothelial cells.

De Nigris V, Pujadas G, La Sala L, Testa R, Genovese S, Ceriello A.

Cardiovasc Diabetol. 2015 Aug 22;14:114. doi: 10.1186/s12933-015-0278-0.

19.

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress.

Ceriello A, La Sala L, De Nigris V, Pujadas G, Rondinelli M, Genovese S.

Ther Clin Risk Manag. 2015 Jun 4;11:901-3. doi: 10.2147/TCRM.S83322. eCollection 2015. No abstract available.

20.

GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Ceriello A, La Sala L, De Nigris V, Pujadas G, Testa R, Uccellatore A, Genovese S.

Endocrine. 2015 Nov;50(2):508-11. doi: 10.1007/s12020-015-0565-2. Epub 2015 Mar 6. No abstract available.

PMID:
25743265

Supplemental Content

Loading ...
Support Center